FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Eugia US Gentamicin Injection Recall

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dos…

Eugia US LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
Jun 25, 2025
Recall ID
D-0472-2025
Check your lot numberHow we source this data

Summary

Eugia US recalled Gentamicin Injection starting May 29, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0472-2025 on Jun 25, 2025. Reason: Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis. Status: Ongoing.

Why it was recalled

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Product description

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Lot numbers, UPCs & expiration codes

Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0472-2025
Classification
Class II
Status
Ongoing
Recall initiated
May 29, 2025
FDA report date
Jun 25, 2025
Quantity
48,000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0472-2025, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
96976
Address
279 Princeton Hightstown Rd
Code information
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
Postal code
08520-1401
Report date
Jun 25, 2025
Product type
Drugs
Recall number
D-0472-2025
Classification
Class II
Recalling firm
Eugia US LLC
Product quantity
48,000 vials
Reason for recall
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
Distribution pattern
Nationwide in the USA
Recall initiation date
May 29, 2025
Initial firm notification
Letter
Center classification date
Jun 18, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0472-2025, published Jun 25, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls